Table 2

Allergic and anaphylactic reactions following BPG administration for RHD prophylaxis

StudyYearDemographicsAllergic reactionsAnaphylactic reactionsFatalities
Number of events
(total patients)
%Number of events (total patients)%
Stollerman et al151952Children (6–14 years)4 (135)3.00 (135)00
Diehl et al431954Children (5–20 years)2 (96)2.10 (96)00
Stollerman et al151955Children (6–16 years)5 (410)1.20 (410)00
Hsu and Evans161958Adults (20–54 years)6 (32)18.71 (32)3.11
Steigmann and Suker171962Adults
(19yo, 49yo, ‘middle-aged woman’)
N/AN/A3 (3)1003
Lue et al101976Children (age not specified)7 (105)6.72 (105)1.9N/R
Markowitz and Lue391991Children and adults (5–28 years)57 (1792)3.24 (1792)0.21
WHO442000Children (10–14 years)N/AN/A2 (2)1002
Regmi and Upadhyaya212011Children and adults (age not specified)65 (4712)1.45 (4712)0.10
Kaya et al222014Children (5–16 years)11 (535)2.10 (535)00
Sani et al242015Children (0–15 years)N/AN/A1 (47)N/A0
Kalani et al232016Adults (40yo)N/AN/A1 (1)N/A1
Berkovitch et al112018Children and adults (10–91 years)N/AN/A2 (2)N/A2
Total1572110
  • BPG, benzathine penicillin G; N/R, not reported; RHD, rheumatic heart disease.